Skip to main content
TipRanks
Go Ultimate75% OFF

James Edward Smith Insider Profile

4 Followers

James Edward Smith, former Ten Percent Owner at Pernix Therapeutics, holds 3.50M shares in Pernix Therapeutics (Ticker: PTXTQ). Most recently, James Edward Smith Sold 194,600 shares of Pernix Therapeutics on May 21, 2014 for an estimated value of $1.19M.

James Edward Smith's Trading History

PTXTQ
Pernix Therapeutics
May 21, 2014―Informative Sell1.19M$98.05K
PTXTQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 21, 2014Informative Sell$1.19M194,600$6.12-6.30%
May 16, 2014Informative Sell$1.90M310,200$6.11-7.80%
May 14, 2014Informative Sell$1.58M289,400$5.45-15.50%
May 09, 2014Informative Sell$196.35K45,000$4.36-41.40%
May 06, 2014Informative Sell$199.65K45,000$4.43-51.80%

You May Also Like

James Edward Smith insider profile FAQ

What is the percentage of profitable transactions made by James Edward Smith?
The percentage of profitable transactions made by James Edward Smith is 0%.
What is the average return per transaction made by James Edward Smith?
The average return per transaction made by James Edward Smith is -31.30%.
What stocks does James Edward Smith hold?
James Edward Smith holds: PTXTQ stocks.
What was James Edward Smith’s latest transaction?
James Edward Smith’s latest transaction was an Informative Sell of $1.19M.
What was James Edward Smith's most profitable transaction?
James Edward Smith’s most profitable transaction was an Informative Sell of PTXTQ stock on May 21, 2014. The return on the trade was -6.30%.
What is James Edward Smith's role in Pernix Therapeutics?
James Edward Smith's role in Pernix Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.